Santa Cruz, CA, United States of America

Bradley E Loe


 

Average Co-Inventor Count = 5.6

ph-index = 6

Forward Citations = 117(Granted Patents)


Company Filing History:


Years Active: 1995-2014

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: The Innovative Contributions of Bradley E. Loe

Introduction

Bradley E. Loe, an accomplished inventor based in Santa Cruz, California, has made significant strides in the field of pharmaceuticals. With a portfolio of nine patents, his work primarily revolves around novel compounds that target specific proteins associated with various diseases.

Latest Patents

Among his latest innovations, one notable patent focuses on compounds of the formula I: or pharmaceutically acceptable salts thereof, specifically designed as P2X7 modulators. These compounds can be utilized in treating diseases linked to the P2X7 purinergic receptor. Additionally, his work on inhibitors of Bruton's tyrosine kinase presents derivatives such as 5-phenyl-1H-pyridin-2-one and 6-phenyl-2H-pyridazin-3-one. These compounds aim to modulate Btk activity, aiding in the treatment of inflammatory and autoimmune diseases like rheumatoid arthritis.

Career Highlights

Throughout his career, Bradley has been associated with notable companies such as Roche Palo Alto LLC and Syntex (U.S.A.) Inc. His dedication to research and development has positioned him as a valuable asset in the field of medicinal chemistry.

Collaborations

Bradley has collaborated with talented professionals in the industry, including Rama K. Kondru and Yan Lou. These partnerships have played a crucial role in advancing his research and patent applications.

Conclusion

In summary, Bradley E. Loe’s innovative contributions to pharmaceutical sciences and his impressive portfolio of patents underscore his impact as an inventor. His work not only paves the way for new treatments but also highlights the importance of collaboration in scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…